Skip to content

Drug interactions

Apalutamide + Buprenorphine long-acting

Severity: Moderate

Apalutamide and Buprenorphine long-acting: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide may reduce buprenorphine concentrations from long-acting injection through enzyme induction. This could cause withdrawal symptoms or reduced treatment effect in opioid use disorder.

What this interaction means in plain words

Apalutamide and Buprenorphine long-acting can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Induction of CYP3A4-mediated metabolism of buprenorphine increases its clearance.

What to do

Monitor for withdrawal, cravings and illicit opioid use, and consider supplemental dosing or an alternative to apalutamide. Reassess when apalutamide is discontinued.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Buprenorphine long-acting, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Buprenorphine long-acting?

MediHelp rates the interaction as moderate. Apalutamide and Buprenorphine long-acting can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Apalutamide may reduce buprenorphine concentrations from long-acting injection through enzyme induction. This could cause withdrawal symptoms or reduced treatment effect in opioid use disorder.

How serious is the interaction between Apalutamide and Buprenorphine long-acting?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for withdrawal, cravings and illicit opioid use, and consider supplemental dosing or an alternative to apalutamide. Reassess when apalutamide is discontinued.

What other medicines interact with Apalutamide?

MediHelp also lists interactions of Apalutamide with, for example, Cabotegravir, Cobicistat, Doravirine. The full list is on the Apalutamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in